Skip to main content

Table 3 Performance of careHPV and genotyping to detect cases of cytological abnormalities (LSIL and greater, n = 8) among 197 study participants in Cape Coast, Ghana

From: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

Performance Indicators careHPV
% (95%CI)
Anyplex II HPV 28
% (95%CI)
Number of LSIL+ cases detected by assay 7 7
Sensitivity 87.5 (47.3–99.7) 87.5 (47.3–99.7)
Specificity 52.1 (44.7–59.5) 38.8 (31.8–46.2)
Positive predictive value (PPV) 7.2 (3.0–14.3) 5.7 (2.3–11.5)
Negative predictive value (NPV) 99.0 (94.5–100.0) 98.6 (92.7–100.0)